Revision History

Bayer's proposed $7.25 billion Roundup class action settlement faces constitutional objections, a federal judge's scathing criticism, and an attempt to remove the case from state to federal court — all while the U.S. Supreme Court weighs a separate preemption case that could reshape the entire litigation. With over $22 billion already spent or committed on Roundup-related costs and the company's market capitalization down more than 50% since acquiring Monsanto, the outcome will set precedent for mass tort litigation involving contested science for years to come.